Benchmarking the in vitro activity of moxifloxacin against recent isolates of Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae. A European multi-centre study
- 17 July 2000
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 37 (3) , 203-211
- https://doi.org/10.1016/s0732-8893(00)00128-0
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Decreased Susceptibility ofStreptococcus pneumoniaeto Fluoroquinolones in CanadaNew England Journal of Medicine, 1999
- Comparative susceptibility to penicillin and quinolones of 1385 Streptococcus pneumoniae isolatesJournal of Antimicrobial Chemotherapy, 1999
- Trends in the Antimicrobial Susceptibility of Bacterial Respiratory Tract Pathogens - Findings of the Alexander Project 1992-1996Journal of Chemotherapy, 1999
- Prevalence of a Putative Efflux Mechanism among Fluoroquinolone-Resistant Clinical Isolates of Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 1998
- Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance studyJournal of Antimicrobial Chemotherapy, 1996
- Community-Acquired PneumoniaNew England Journal of Medicine, 1995
- Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsisAntimicrobial Agents and Chemotherapy, 1993
- Role of pharmacokinetics in the outcome of infectionsAntimicrobial Agents and Chemotherapy, 1988
- World-wide development of antibiotic resistance in pneumococciEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistanceAntimicrobial Agents and Chemotherapy, 1987